Immediate Impact
94 standout
Citing Papers
Dilated cardiomyopathy: causes, mechanisms, and current and future treatment approaches
2023 Standout
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): health status analysis of a randomised, double-blind, placebo-controlled, phase 3 trial
2021 Standout
Works of Jean-Philippe Simon being referenced
Cardiac Abnormalities in Type 1 Facioscapulohumeral Muscular Dystrophy
2017
DDD pacing in hypertrophic cardiomyopathy: a multicentre clinical experience.
1996
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Jean-Philippe Simon | 217 | 200 | 23 | 86 | 15 | 354 | |
| A. W. Branwood | 86 | 88 | 25 | 59 | 17 | 313 | |
| J F Silverman | 140 | 182 | 19 | 120 | 11 | 317 | |
| Kayıhan Akın | 60 | 150 | 25 | 36 | 24 | 311 | |
| Anne Günther | 92 | 82 | 32 | 55 | 19 | 349 | |
| Stefan Hassenstein | 170 | 184 | 50 | 53 | 10 | 342 | |
| Costantino Smaldone | 204 | 47 | 41 | 21 | 16 | 408 | |
| Marcus Hjort | 200 | 92 | 33 | 117 | 16 | 385 | |
| Yongle Ruan | 184 | 196 | 81 | 39 | 24 | 379 | |
| M. Denise Daley | 63 | 223 | 34 | 59 | 18 | 390 | |
| R A Hurlow | 61 | 133 | 18 | 21 | 20 | 326 |
All Works
Loading papers...